StockData
Lucid Diagnostics Inc. logo

Lucid Diagnostics Inc. (LUCD) stock

LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3034% above fair value
$0.40−0.05 (-11.42%)

Close on Nov 16, 2026Market cap $80.85MP/E –Yield –

Lucid Diagnostics total assets

Total assets on the balance sheet at the end of each period.

Lucid Diagnostics's total assets was $38.95M at Jun 30, 2026. For fiscal 2025 it was $40.45M, up 31.7% from the year before. The highest annual figure on record is $59.00M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$40.45M+31.7%
FY2024Dec 31, 2024$30.72M+12.6%
FY2023Dec 31, 2023$27.27M-16.1%
FY2022Dec 31, 2022$32.51M-44.9%
FY2021Dec 31, 2021$59.00M+2587.9%
FY2020Dec 31, 2020$2.20M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$38.95M+0.7%
Q1 FY2026Mar 31, 2026$34.08M+3.9%
Q4 FY2025Dec 31, 2025$40.45M+31.7%
Q3 FY2025Sep 30, 2025$53.20M+135.4%
Q2 FY2025Jun 30, 2025$38.67M+13.4%
Q1 FY2025Mar 31, 2025$32.80M+2.3%
Q4 FY2024Dec 31, 2024$30.72M+12.6%
Q3 FY2024Sep 30, 2024$22.60M-32.0%
Q2 FY2024Jun 30, 2024$34.11M-19.7%
Q1 FY2024Mar 31, 2024$32.05M-34.8%
Q4 FY2023Dec 31, 2023$27.27M-16.1%
Q3 FY2023Sep 30, 2023$33.24M-13.4%
Q2 FY2023Jun 30, 2023$42.49M-6.4%
Q1 FY2023Mar 31, 2023$49.13M-20.8%
Q4 FY2022Dec 31, 2022$32.51M-44.9%
Q3 FY2022Sep 30, 2022$38.38M+1064.2%
Q2 FY2022Jun 30, 2022$45.40M+1968.4%
Q1 FY2022Mar 31, 2022$62.06M–
Q4 FY2021Dec 31, 2021$59.00M–
Q3 FY2021Sep 30, 2021$3.30M–
Q4 FY2020Dec 31, 2020$2.20M–

More Lucid Diagnostics figures

See a number that looks wrong?